Skip to main content

Table 3 Fold changes in gene expression in cells treated with triptolide (55.5 nM) as compared to endogenous expression levels in untreated cells.

From: MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages

a) Downregulation (≤-3) of LPS-non responsive genes by triptolide.

Gene symbol

Accession No.

Gene Name

Fold change in response to triptolide

Bcl6

NM_009744

B-cell leukemia/lymphoma 6

-5.36

Cxcr3

NM_009910

Chemokine (C-X-C motif) receptor 3

-7.63

Tnfrsf1a

NM_011609

Tumor necrosis factor receptor superfamily, member 1a

-5.18

Eif2ak2

NM_011163

Eukaryotic translation initiation factor 2-alpha kinase 2

-4.51

Tlr3

NM_126166

Toll-like receptor 3

-10.73

Tlr7

NM_133211

Toll-like receptor 7

-12.85

Ly96

NM_016923

Lymphocyte antigen 96

-4.28

Map2k4

NM_009157

Mitogen activated protein kinase kinase 4

-3.01

b) Upregulation (≥+3) of LPS-non responsive genes by triptolide.

Gene symbol

Accession No.

Gene Name

Fold change in response to triptolide

Ccl25

NM_009138

Chemokine (C-C motif) ligand 25

6.05

Fasl

NM_010177

Fas ligand (TNF superfamily, member 6)

115.09

Irf1

NM_008390

Interferon regulatory factor 1

7.60

Mapk3

NM_011952

Mitogen activated protein kinase 3

5.84

Tnfsf14

NM_019418

Tumor necrosis factor (ligand) superfamily, member 14

17.71

Traf3

NM_011632

Tnf receptor-associated factor 3

3.38

  1. LPS (1 μg/ml) did not have any effect on these genes.